Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.	Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryptogenic Ischemic Stroke, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, ischemic stroke, nervous system disorder, patent foramen ovale, stroke disorder, vascular disorder	Recruiting	Not applicable	2023-09-01		NCT05774288

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Lifetech Scientific (Shenzhen) Co., Ltd.	25

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fuwai Hospital ，CAMS&PUMC	Beijing	China	1
Fuwai Yunnan Cardiovascular Hospital	Kunming	China	2
General Hospital of Northern Theater Command	Shenyang	China	1
Meizhou people'Hospital	Meizhou	China	1
Peking University First Hospital	Beijing	China	163
Qilu Hospitalof Shandong University	Jinan	China	1
The first affiliated hospital of Ningbo university	Ningbo	China	35
The first affiliated hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)	Jinan	China	2
The First Affiliated Hospital of Wenzhou Medical University	Wenzhou	China	87
The First Affiliated Hospital, Sun Yat-sen University	Guangzhou	China	32
The First Hospital Of JiLin Universitv	Changchun	China	1
The Second Xiangya Hospital of Central South University	Changsha	China	12
The Third Xiangya Hospital of Central South University	Changsha	China	11
Zhejiang Provincial People's Hospital	Hangzhou	China	48